INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/26/2025
Back to search
Official data from USPTO
NEOHEME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEOHEME
ST13
US500000079211725Class
5, 42, 44
Filing
79211725
Registration
5383046
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
07/27/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
01/25/2017
Registration date
01/23/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/09/2024
Last transaction
07/27/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
27
Owner location
DE
Examiner
LAM, HAI-LY
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Siemens Healthcare GmbH
Representatives
Karla M. Weyand SIEMENS HEALTHCARE DIAGNOSTICS INC.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the detection and analysis of cancer and veterinary preparations for the detection and analysis of cancer; diagnostic preparations for medical purposes; chemical preparations for analyses in laboratorieschemical preparations for the analysis of cancer for medical or veterinary purposes; biological preparations for medical purposesfor the detectionanalysis and treatment of cancer; cultures of microorganisms for medical and veterinary use
Class 42
Scientific and technological servicesmedical testing in the fields of identificationanalysis and treatment of cancer and cancerous diseases for medical research purposes and new product research and design relating thereto; industrial analysis and research services in the fields of identificationanalysis and treatment of cancer and cancerous diseases; scientific research for medical purposes; genetic and proteomic research studies of specimens; providing medical and scientific research in the fields of oncologymolecular profilinggenomics and proteomics; conducting clinical trials for cancer research on behalf of others; design and development of computer hardware and computer software
Class 44
Medical servicesin particular medical analysis in connection with the diagnosis and treatment of cancer and cancerous diseases in individuals; medical testing for diagnosis and treatment of cancer and cancerous diseases provided by a medical laboratory; providing of information in the fields of medicineveterinary medicine and the diagnosticprophylactic and therapeutic properties of pharmaceuticals; medical servicesmedical diagnostictheranosticprognostic and analytical servicesincluding molecular diagnostics for the diagnosis and treatment of cancer and cancerous diseases
Publications
History of USPTO decisions and trademark events.
37 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/09/2025
INPC
INVALIDATION PROCESSED
07/09/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
04/09/2025
C71T
CANCELLED SECTION 71
08/09/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/23/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/24/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/15/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/02/2018
FIMP
FINAL DISPOSITION PROCESSED
05/02/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/23/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
01/23/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2017
PUBO
PUBLISHED FOR OPPOSITION
11/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/18/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/03/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
09/20/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/20/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
09/20/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/20/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/31/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/31/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/30/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/30/2017
ALIE
ASSIGNED TO LIE
08/28/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/10/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/09/2017
RFNT
REFUSAL PROCESSED BY IB
08/04/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/18/2017
RFRR
REFUSAL PROCESSED BY MPU
07/17/2017
MAFR
APPLICATION FILING RECEIPT MAILED
07/15/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/14/2017
CNRT
NON-FINAL ACTION WRITTEN
07/13/2017
DOCK
ASSIGNED TO EXAMINER
07/11/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/06/2017
Continuous trademark protection
Get notified about every new filing that threatens NEOHEME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.